Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1423123생성일: 2026년 10월 25일
Bromide ion → (S)-2-(2-benzyl-4-(3-(cyclopentyloxy)-4-methoxyphenyl)piperazin-1-yl)acetamide
https://huagongshe.com/reaction/1423123
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Bromide ion | HCID 259 | — |
| 반응물 | 2-Bromoacetamide | HCID 69632 | — |
| 반응물 | Diisopropylethylamine | HCID 81531 | — |
| 반응물 | (S)-3-Benzyl-1-(3-cyclopentyloxy-4-methoxy-phenyl)-piperazine | HCID 16725642 | — |
| 용매 | Tetrahydrofuran | HCID 8028 | — |
| 생성물 | (S)-2-(2-benzyl-4-(3-(cyclopentyloxy)-4-methoxyphenyl)piperazin-1-yl)acetamide | HCID 23627744 | 22% |
반응 단계
A solution of the bishydrochloride salt of (S)-3-Benzyl-1-(3-cyclopentyloxy-4-methoxy-phenyl)-piperazine (110 mg, 0.25 mmol) in THF (2 mL) at room temperature was treated with diisopropylethylamine (165 μL, 1.0 mmol) followed by 2-bromoacetamide (42 mg, 0.3 mmol). The reaction mixture was heated at 50° C. for 8 h and an additional amount of bromide (42 mg, 0.3 mmol) then added. The reaction mixture was then stirred for an additional 16 h at room temperature and evaporated. The crude reaction was then partitioned between EtOAc (3 mL) and a saturated aqueous NaHCO3 solution (3 mL). The organic phase was isolated and further washed with an additional portion of a saturated aqueous NaHCO3 solution (3 mL) and brine (2×3 mL). The organic component was dried over MgSO4, filtered, and evaporated to an oil which was purified by silica gel flash chromatography with 80% EtOAc/hexane then 5% MeOH/EtOAc as eluant to afford the title compound as an oil (23 mg, 22%). LC/MS (Method A) 5.09 min, [M+1]+ 424.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08927546B2 |
|---|
| 출처 데이터셋 | uspto-grants-2015_01 |
|---|
| ORD ID | ord-58ab71e151d34151aedbfdfd911b5e44 |
|---|
| 출처 메모 | uspto-grants-2015_01 |
|---|